ArticlePediatric surgery international2025
Outcomes of major liver resection for children with hepatoblastoma weighing less than 10 kg: avoiding liver transplantation with extended or extreme resection.
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatoblastoma is a rare disease and major hepatectomy in small children is technically challenging surgery due to small size of blood vessels, bile ducts, small liver volume, and the challenge of intraoperative monitoring. Detailed information about surgical outcomes of major liver resection in children with HB weighing < 10 kg are limited. The threshold of the future liver remnant (FLR) in children remains controversial and is not defined. We aim to report our institutional experience of major liver resection in children with HB weighing < 10 Kg.
methodsA single center retrospective analytic study of pediatric patients diagnosed with HB undergoing major liver resection from January 2010 to March 2024 at a tertiary referral hospital and transplant center. Demographic variables, tumor variables, radiographic data, surgical details, postoperative outcomes were collected. The patients were divided into < 10 kg and ≥ 10 kg and compared. The patients who underwent extended or extreme liver resection were subgroup analyzed.
resultsForty-three patients were included, 26 (60%) < 10 kg and 17 (40%) ≥ 10 Kg. Median age at surgery of < 10 kg group was 9 months and of ≥ 10 kg group was 19 months (p = 0.04). Median weight of < 10 kg group was 8.2 kg [IQR 7.12–9]. The majority of < 10 kg patients had POSTTEXT 2 (62%) and 3 (31%). Patient weighing < 10 kg had slightly higher median operative time (240 vs. 220 min, p = 0.55) and higher median blood loss (107 vs. 80 ml, p = 0.63). There were also no significant differences in rate of blood transfusion, length of hospital, and ICU stays between two groups. There were no significant differences in overall survival and disease-free survival between < 10 kg and ≥ 10 kg (90% vs. 68%, p = 0.2, and 80% vs. 61%, p = 0.22, respectively). Eleven (26%) patients underwent extended or extreme liver resection; 10/11 weighed < 10 kg with minimum body weight at 6.8 Kg. FLR to body weight (BW) ratio (FLV/BW) was between 1.4 and 2.9% and 11.9–41% of FLR/total liver volume (TLV).
conclusionsSurgical outcomes of major liver resection and surgical complications in children with HB weighing < 10 kg were comparable to ≥ 10 kg children. There was no incidence of mortality rate related to surgical complication or biliary complication in our cohort. Our study also highlighted that extended or extreme liver resection was feasible and safe to perform in < 10 kg children with HB. FLR/BW ratio between 1.4 and 2.9% was not associated with PHLF in children < 10 Kg; however, a further larger study is required. LEVEL OF EVIDENCE: Level 3 retrospective study.
Indexed as
Identifiers
41307727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.